SCHEMBL8871003

SCHEMBL8871003

CC(=O)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.76
ERBB2 P04626 4/20 0.72
ABCG2 Q9UNQ0 1/20 0.69
HDAC3 O15379 1/20 0.68
HDAC4 P56524 1/20 0.68
HDAC1 Q13547 1/20 0.68
HDAC7 Q8WUI4 1/20 0.68
HDAC2 Q92769 1/20 0.68
HDAC10 Q969S8 1/20 0.68
HDAC11 Q96DB2 1/20 0.68
HDAC8 Q9BY41 1/20 0.68
HDAC6 Q9UBN7 1/20 0.68
HDAC9 Q9UKV0 1/20 0.68
HDAC5 Q9UQL6 1/20 0.68
PIM1 P11309 1/20 0.67
MKNK2 Q9HBH9 1/20 0.67
NFKB1 P19838 1/20 0.66
NFKB2 Q00653 1/20 0.66
RELA Q04206 1/20 0.66
KDM4E B2RXH2 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2100347 0.87 EGFR (0.77) EGFRERBB2ABCG2HTT
SCHEMBL27758510 0.87 EGFR (0.76) EGFRERBB2ABCG2KDM4EHTT
SCHEMBL12012727 0.86 EGFR (1.00) EGFRERBB2ABCG2
SCHEMBL9974895 0.86 EGFR (0.76) EGFRERBB2ABCG2
SCHEMBL2986894 0.85 EGFR (1.00) EGFRERBB2
SCHEMBL8870637 0.85 EGFR (0.78) EGFRERBB2HDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL3000541 0.84 EGFR (0.98) EGFRERBB2
SCHEMBL27922065 0.84 EGFR (0.69) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL24249504 0.84 GMPS (0.77) EGFRABCG2NPC1HTT
SCHEMBL29392392 0.84 GMPS (0.77) EGFRABCG2NPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616582-A Use as anticancer agents; e.g. gefitinib ZENECA LIMITED (GB) 1997-04-01 US disclosed
EP-0566226-B1 Quinazoline derivatives ZENECA LTD (GB) 1995-11-08 EP disclosed
US-5457105-A anticancer use; e.g. 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline (gefitinib) ZENECA LIMITED (GB) 1995-10-10 US disclosed
EP-0566226-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1993-10-20 EP disclosed